PLACACTIVITY

Accurately assessing patients' risk for CHD events remains a significant challenge in primary prevention... The FDA cleared PLAC Activity Test showed a strong association with CHD events* as compared to traditional risk factors even after adjusting for age, gender, race, diabetes and smoking status. Only complex clinical conditions such as diabetes and smoking status demonstrated greater hazard ratios for CHD events... Effectiveness of the PLAC Activity Test has been demonstrated across multiple clinical trials and patient populations.

Also known as: General Atomics

Primary location: Poway United States